Definition/General

Introduction: Phyllodes tumor with micropapillary carcinoma is an extremely rare malignant phyllodes tumor where the stromal component contains micropapillary carcinoma characterized by small clusters of cells in clear spaces resembling lymphovascular invasion.
Origin:
-Develops from intralobular breast stroma with differentiation toward micropapillary carcinoma
-May arise through specific genetic alterations leading to micropapillary architecture.
Classification:
-WHO Classification categorizes this as malignant phyllodes tumor with heterologous elements
-Micropapillary component shows characteristic pseudovascular spaces.
Epidemiology:
-Exceptionally rare with fewer than 5 cases reported worldwide
-Peak age 45-65 years
-Female predominance
-Associated with high lymph node metastasis rate similar to pure micropapillary carcinoma.

Clinical Features

Presentation:
-Large, firm breast mass
-Usually presents as irregular, spiculated mass
-May show moderate growth rate
-Often clinically suspicious for malignancy.
Symptoms:
-Progressive breast enlargement
-May be painful due to rapid growth
-Skin retraction possible with large tumors
-Breast asymmetry
-Constitutional symptoms rare.
Risk Factors:
-Previous phyllodes tumor history
-Older age
-Family history of breast cancer
-No specific environmental risk factors identified.
Screening:
-Often detected on mammographic screening
-Clinical examination may reveal spiculated mass
-Mammography shows irregular mass with spiculation
-Core needle biopsy essential.

Master Phyllodes Tumor with Micropapillary Carcinoma Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-Large, irregular mass with firm consistency
-Cut surface shows gray-white areas with possible stellate pattern
-Spiculated borders may be present.
Characteristics:
-Size typically >3 cm (range 2-10 cm)
-Firm consistency
-Irregular borders
-Gray-white coloration
-May have central fibrosis.
Size Location:
-Can occur in any breast region
-Usually involves moderate breast tissue
-Unilateral presentation
-May have infiltrative appearance.
Multifocality:
-Typically unifocal mass
-Micropapillary areas may be multifocal within tumor
-Growth pattern may be infiltrative.

Microscopic Description

Histological Features:
-Biphasic tumor with epithelial and mesenchymal components
-Micropapillary carcinoma areas show small clusters of cells in clear spaces lacking endothelial lining, creating pseudovascular pattern.
Cellular Characteristics:
-Small clusters of pleomorphic epithelial cells
-Moderate to high nuclear grade
-Cells appear to float in clear spaces
-Loss of cellular cohesion.
Architectural Patterns:
-Micropapillary clusters in pseudovascular spaces
-Lack of fibrovascular cores
-Stromal retraction artifact
-May mimic lymphovascular invasion.
Grading Criteria:
-Grade 2-3 typically
-Moderate to high nuclear grade
-Moderate mitotic activity
-Micropapillary architecture >50% for pure type.

Immunohistochemistry

Positive Markers:
-EMA positive with reverse polarity
-Cytokeratins positive
-MUC1 positive with apical pattern
-E-cadherin reduced
-Epithelial component: CK7+.
Negative Markers:
-Estrogen receptor variable
-Progesterone receptor variable
-HER2 variable
-CD31 negative (excludes true vessels).
Diagnostic Utility:
-EMA reverse polarity characteristic of micropapillary carcinoma
-MUC1 apical staining pattern
-CD31 negative excludes lymphovascular invasion.
Molecular Subtypes:
-Variable molecular subtype
-May be luminal or triple-negative
-HER2-enriched possible.

Molecular/Genetic

Genetic Mutations:
-PIK3CA mutations common
-TP53 mutations variable
-MYC amplification possible
-Loss of E-cadherin function.
Molecular Markers:
-Variable gene expression profile
-High proliferation markers
-Loss of cell adhesion molecules
-Angiogenesis factors.
Prognostic Significance:
-Poor prognosis due to high lymph node metastasis rate
-Micropapillary component predicts aggressive behavior
-Early systemic therapy important.
Therapeutic Targets:
-Targeted therapy based on receptor status
-Anti-HER2 therapy if amplified
-CDK4/6 inhibitors if hormone receptor positive
-Aggressive chemotherapy.

Differential Diagnosis

Similar Entities:
-Primary micropapillary carcinoma of breast
-Invasive ductal carcinoma with micropapillary features
-Papillary carcinoma
-Lymphovascular invasion.
Distinguishing Features:
-Phyllodes with micropapillary: Leaf-like areas, EMA reverse polarity
-Primary micropapillary: No phyllodes component
-True LVI: CD31+ endothelium.
Diagnostic Challenges:
-Recognition of micropapillary features
-Distinction from lymphovascular invasion
-Assessment of percentage micropapillary component
-Immunohistochemical interpretation.
Rare Variants:
-Micropapillary carcinoma with squamous differentiation
-Mixed micropapillary and ductal carcinoma
-Micropapillary with neuroendocrine features.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

[specimen type], measuring [size] cm in greatest dimension

Diagnosis

[diagnosis name]

Classification

Classification: [classification system] [grade/type]

Histological Features

Shows [architectural pattern] with [nuclear features] and [mitotic activity]

Size and Extent

Size: [X] cm, extent: [local/regional/metastatic]

Margins

Margins are [involved/uninvolved] with closest margin [X] mm

Lymphovascular Invasion

Lymphovascular invasion: [present/absent]

Lymph Node Status

Lymph nodes: [X] positive out of [X] examined

Special Studies

IHC: [marker]: [result]

Molecular: [test]: [result]

[other study]: [result]

Prognostic Factors

Prognostic factors: [list factors]

Final Diagnosis

Final diagnosis: [complete diagnosis]